Bariatric surgery for obesity and metabolic disorders: State of the art

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 3, 2017, Pages 160-169

  Nguyen, Ninh T ^a   Varela, J Esteban ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Diabetes Surgery Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ALGORITHM; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTRIC BANDING; HISTORY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MEDICAL SOCIETY; METABOLIC DISORDER; MINIMALLY INVASIVE SURGERY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DEFICIENCY; OBESITY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; REMISSION; REVIEW; ROUX-EN-Y GASTRIC BYPASS; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; WEIGHT REDUCTION; WOUND COMPLICATION; ADVERSE EFFECTS; COMPLICATION; DIABETES MELLITUS, TYPE 2; LAPAROSCOPY; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; LAPAROSCOPY; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 85000869921     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.170     Document Type: Review

References (64)

1. World Health Organization. Obesity and overweight fact sheet. WHO http://www.who.int/mediacentre/factsheets/fs311/en/(accessed 28 December 2015).
2. Mingrone, G. et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386, 964-973 (2015).
3. Adams, T. D. et al. Long-Term mortality after gastric bypass surgery. N. Engl. J. Med. 357, 753-761 (2007).
4. Esteban Varela, J. & Nguyen, N. T. Laparoscopic sleeve gastrectomy leads the U. S. utilization of bariatric surgery at academic medical centers. Surg. Obes. Relat. Dis. 11, 987-990 (2015).
5. Nguyen, N. T. et al. Laparoscopic versus open gastric bypass: A randomized study of outcomes, quality of life, and costs. Ann. Surg. 234, 279-289 (2001).
6. Blondet, J. J., Morton, J. M. & Nguyen, N. T. Hospital accreditation and bariatric surgery: is it important? Adv. Surg. 49, 123-129 (2015).
7. Chousleb, E., Rodriguez, J. A. & OLeary, J. P. in The ASMBS Textbook of Bariatric Surgery (eds Nguyen, N. T., Blackstone, R. P., Morton, J. M., Ponce, J. & Rosenthal, R. J.) 37-46 (Springer, 2015).
8. Ponce, J., Nguyen, N. T., Hutter, M., Sudan, R. & Morton, J. M. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg. Obes. Relat. Dis. 11, 1199-2000 (2015).
9. Puzziferri, N., Austrheim-Smith, I. T., Wolfe, B. M., Wilson, S. E. & Nguyen, N. T. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann. Surg. 243, 181-188 (2006).
10. Dixon, J. B., Zimmet, P., Alberti, K. G., Rubino, F & International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: An IDF statement for obese type 2 diabetes. Arq. Bras. Endocrinol. Metabol. 55, 367-382 (2011).
11. Jensen, M. D. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation 129 (Suppl. 2), S102-S138 (2014).
12. Handelsman, Y. et al. American Association of Clinical Endocrinologists and American College of Endocrinology-clinical practice guidelines for developing a diabetes mellitus comprehensive care plan-2015. Endocr. Pract. 21 (Suppl. 1), 1-87 (2015).
13. American Diabetes Association. Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care 38 (Suppl. 1), S4 (2015).
14. Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311, 806-814 (2014).
15. Finklestein, E. A., Trogdon, J. G., Cohen, J. W. & Dietz, W. Annual medical spending attributable to obesity: payer-And service-specific estimates. Health Aff. (Millwood) 28, w822-w831 (2009).
16. Hammond, R. A. & Levine, R. The economic impact of obesity in the United States. Diabetes Metab. Syndr. Obes. 3, 285-295 (2010).
17. Angrisani, L. et al. Bariatric surgery worldwide 2013. Obes. Surg. 25, 1822-1832 (2015).
18. Mason, E. E. & Ito, C. Gastric bypass in obesity. Surg. Clin. North Am. 47, 1345-1351 (1967).
19. Hocking, M. P., Duerson, M. C., OLeary, J. P. & Woodward, E. R. Jejunoileal bypass for morbid obesity-late follow-up in 100 cases. N. Engl. J. Med. 308, 995-999 (1983).
20. Maclean, L. D., Rhode, B. M. & Forse, R. A. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery 107, 20-27 (1990).
21. Scopinaro, N. et al. Surgical revision of biliopancreatic diversion. Gastroenterol. Clin. North Am. 16, 529-531 (1987).
22. Hess, D. S. & Hess, D. W. Biliopancreatic diversion with a duodenal switch. Obes. Surg. 8, 267-282 (1998).
23. Marceau, P. et al. Biliopancreatic diversion with duodenal switch. World J. Surg. 22, 947-954 (1998).
24. Regan, J. P., Inabnet, W. B., Gagner, M. & Pomp, A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes. Surg. 13, 861-864 (2003).
25. ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg. Obes. Relat. Dis. 8, e21-e26 (2012).
26. Wittgrove, A. C., Clark, G. W. & Tremblay, L. G. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes. Surg. 4, 353-357 (1994).
27. Nguyen, N. T., Ho, H. S., Palmer, L. S. & Wolfe, B. M. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J. Am. Coll. Surg. 191, 149-155 (2000).
28. Nguyen, N. T., Hinojosa, M., Fayad, C., Varela, E. & Wilson, S. E. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J. Am. Coll. Surg. 205, 248-255 (2007).
29. Nguyen, N. T., Vu, S., Kim, E., Bodunova, N. & Phelan, M. J. Trends in utilization of bariatric surgery, 2009-2012. Surg. Endosc. 30, 2723-2727 (2016).
30. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann. Intern. Med. 115, 956-961 (1991).
31. Rubino, F. et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann. Surg. 244, 741-749 (2006).
32. Kashyap, S. R., Bhatt, D. L., Schauer, P. R. & STAMPEDE Investigators. Bariatric surgery versus advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes. Metab. 12, 452-454 (2010).
33. Dixon, J. B. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 299, 316-323 (2008).
34. ASMBS Clinical Issues Committee. Bariatric surgery in class I obesity (body mass index 30-35 kg/m2). Surg. Obes. Relat. Dis. 9, e1-e10 (2013).
35. OBrien, P. E. et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: A randomized trial. Ann. Intern. Med. 144, 625-633 (2006).
36. Kumar, R. et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 149, 654-661 (2011).
37. Cohen, R. V., Rubino, F., Schiavon, C. & Cummings, D. E. Diabetes remission without weight loss after duodenal bypass surgery. Surg. Obes. Relat. Dis. 8, e66-e68 (2012).
38. Buchwald, H. et al. Bariatric surgery: A systematic review and meta-Analysis. JAMA 292, 1724-1737 (2004).
39. Wang, Y. & Liu, J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes. Surg. 19, 357-362 (2009).
40. Bradley, D. et al. Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects. Obesity (Silver Spring) 22, 2026-2031 (2014).
41. Chang, S. H. et al. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-Analysis, 2003-2012. JAMA Surg. 149, 275-287 (2014).
42. Hutter, M. M. et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann. Surg. 254, 410-420 (2011).
43. Himpens, J. et al. Long-Term outcomes of laparoscopic adjustable gastric banding. Arch. Surg. 146, 802-807 (2011).
44. Kindel, T., Martin, E., Hungness, E. & Nagle, A. High failure rate of the laparoscopic-Adjustable gastric band as a primary bariatric procedure. Surg. Obes. Relat. Dis. 10, 1070-1075 (2014).
45. Altieri, M. S. et al. Lap band outcomes from 19, 221 patients across centers and over a decade within the state of New York. Surg. Endosc. 30, 1725-1732 (2016).
46. Mingrone, G. et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 366, 1577-1585 (2012).
47. Morton, J. M., Garg, T. & Nguyen, N. Does hospital accreditation impact bariatric surgery safety? Ann. Surg. 260, 504-508 (2014).
48. Villamere, J., Gebhart, A., Vu, S. & Nguyen, N. T. Utilization and outcome of laparoscopic versus robotic general and bariatric surgical procedures at Academic Medical Centers. Surg. Endosc. 29, 1729-1736 (2015).
49. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N. Engl. J. Med. 361, 445-454 (2009).
50. Buchwald, H., Estok, R., Fahrbach, K., Banel, D. & Sledge, I. Trends in mortality in bariatric surgery: A systematic review and meta-Analysis. Surgery 142, 621-632 (2007).
51. Inge, T. H. et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N. Engl. J. Med. 374, 113-123 (2016).
52. Inge, T. H. et al. Perioperative outcomes of adolescents undergoing bariatric surgery: The Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr. 168, 47-53 (2014).
53. Gebhart, A., Young, M. T. & Nguyen, N. T. Bariatric surgery in the elderly: 2009-2013. Surg. Obes. Relat. Dis. 11, 393-398 (2015).
54. Ikramuddin, S. et al. Roux-en-Y gastric bypass versus intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The Diabetes Surgery Study randomized clinical trial. JAMA 309, 2240-2249 (2013).
55. Courcoulas, A. P. et al. Three-year outcomes of bariatric surgery versus lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial. JAMA Surg. 150, 931-940 (2015).
56. Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy for diabetes-3 year outcomes. N. Engl. J. Med. 370, 2002-2013 (2014).
57. Cummings, D. E. et al. Gastric bypass surgery versus intentive lifestyle and medical intervention for type 2 diabetes: The CROSSROADS randomised controlled trial. Diabetologia 59, 945-953 (2016).
58. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study. Obesity (Silver Spring) 22, 5-13 (2014).
59. Buchwald, H. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-Analysis. Am. J. Med. 122, 248-256.e5 (2009).
60. Grundy, S. M. et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institue/American Heaty Association conference on scientific issues related to definition. Circulation 109, 433-438 (2004).
61. Batsis, J. A. et al. Effect of bariatric surgery on the metabolic syndrome: A population-based, long-Term controlled study. Mayo Clin. Proc. 83, 897-907 (2008).
62. Sjostrom, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741-752 (2007).
63. Sarr, M. G. et al. The EMPOWER study: randomized, prospective, double-blind, ulticentre trial of vagal blockade to induce weight loss in morbid obesity. Obes. Surg. 22, 1771-1782 (2012).
64. Ponce, J. et al. The REDUCE pivotal trial: A prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg. Obes. Relat. Dis. 11, 874-878 (2015).